Join
Live feed
·
PRReleasevia Quantisnow
AstraZeneca PLC logo
Sierra Oncology Inc. logo

Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLCSRRA· Sierra Oncology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC), SRRA (Sierra Oncology Inc.) and more on Quantisnow.